National Cancer Registry (2022) Cancer statistics. In: Natl. Inst. Commun. Dis. Natl. Health Lab. Serv. https://www.nicd.ac.za/centres/national-cancer-registry/. Accessed 19 Jun 2024

Tung N, Battelli C, Allen B, Kaldate R, Bhatnagar S, Bowles K, Timms K, Garber JE, Herold C, Ellisen L, Krejdovsky J, DeLeonardis K, Sedgwick K, Soltis K, Roa B, Wenstrup RJ, Hartman AR (2015) Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer 121:25–33. https://doi.org/10.1002/CNCR.29010

Article  CAS  PubMed  Google Scholar 

Buys SS, Sandbach JF, Gammon A, Patel G, Kidd J, Brown KL, Sharma L, Saam J, Lancaster J, Daly MB (2017) A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Cancer 123:1721–1730. https://doi.org/10.1002/CNCR.30498

Article  CAS  PubMed  Google Scholar 

Ahearn TU, Choudhury PP, Derkach A, Wiafe-Addai B, Awuah B, Yarney J, Edusei L, Titiloye N, Adjei E, Vanderpuye V, Aitpillah F, Dedey F, Oppong J, Osei-Bonsu EB, Duggan MA, Brinton LA, Allen J, Luccarini C, Baynes C, Carvalho S, Dunning AM, Davis Lynn BC, Chanock SJ, Hicks BD, Yeager M, Chatterjee N, Biritwum R, Clegg-Lamptey JN, Nyarko K, Wiafe S, Ansong D, Easton DF, Figueroa JD, Garcia-Closas M (2022) Breast cancer risk in women from ghana carrying rare germline pathogenic mutations. Cancer Epidemiol Biomarkers Prev 31:1593–1601. https://doi.org/10.1158/1055-9965.EPI-21-1397

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng Y, Walsh T, Gulsuner S, Casadei S, Lee MK, Ogundiran TO, Ademola A, Falusi AG, Adebamowo CA, Oluwasola AO, Adeoye A, Odetunde A, Babalola CP, Ojengbede OA, Odedina S, Anetor I, Wang S, Huo D, Yoshimatsu TF, Zhang J, Felix GES, King M-C, Olopade OI (2018) Inherited breast cancer in nigerian women. J Clin Oncol 36:2820–2825. https://doi.org/10.1200/JCO.2018.78.3977

Article  CAS  PubMed  PubMed Central  Google Scholar 

Adedokun B, Zheng Y, Ndom P, Gakwaya A, Makumbi T, Zhou AY, Yoshimatsu TF, Rodriguez A, Madduri RK, Foster IT, Sallam A, Olopade OI, Huo D (2020) Prevalence of inherited mutations in breast cancer predisposition genes among women in Uganda and Cameroon. Cancer Epidemiol Biomarkers Prev 29:359–367. https://doi.org/10.1158/1055-9965.EPI-19-0506

Article  PubMed  Google Scholar 

Lalloo F, Evans DG (2012) Familial breast cancer. Clin Genet 82:105–114. https://doi.org/10.1111/j.1399-0004.2012.01859.x

Article  CAS  PubMed  Google Scholar 

Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Goggins M, Hutton CGC, Karlan BY, Khan S, Klein C, Kohlmann W, Kurian AW, Laronga C, Litton JK, Mak LCGC, Menendez CS, Merajver SD, Norquist BS, Offit K, Pederson HJ, Reiser CGC, Senter-Jamieson CGC, Shannon KM, Shatsky R, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Yurgelun MB, Darlow SD, Dwyer MA (2021) Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 19:77–102. https://doi.org/10.6004/jnccn.2021.0001

Article  CAS  PubMed  Google Scholar 

NCCN Guidelines (2024) Genetic/familial high-risk assessment: breast and ovarian v3.2024. https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf. Accessed 13 Aug 2024

Marmolejo DH, Zheng Wong MY, Bajalica-Lagercrantz S, Tischkowitz M, Balmaña J, Patócs AB, Chappuis P, Colas C, Genuardi M, Haanpää M, Vetti HH, Hoogerbrugge N, Irmejs A, Kahre T, Klink B, Krajc M, Milagre TH, de Putter R, Steinke-Lange V, Wadt K, Wimmer K (2021) Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe. Eur J Med Genet 64:104350. https://doi.org/10.1016/j.ejmg.2021.104350

Article  CAS  PubMed  Google Scholar 

Beitsch PD, Whitworth PW, Hughes K, Patel R, Rosen B, Compagnoni G, Baron P, Simmons R, Smith LA, Grady I, Kinney M, Coomer C, Barbosa K, Holmes DR, Brown E, Gold L, Clark P, Riley L, Lyons S, Ruiz A, Kahn S, MacDonald H, Curcio L, Hardwick MK, Yang S, Esplin ED, Nussbaum RL (2019) Underdiagnosis of hereditary breast cancer: are genetic testing guidelines a tool or an obstacle? J Clin Oncol 37:453–460. https://doi.org/10.1200/JCO.18.01631

Article  PubMed  Google Scholar 

Samadder NJ, Riegert-Johnson D, Boardman L, Rhodes D, Wick M, Okuno S, Kunze KL, Golafshar M, Uson PLS Jr, Mountjoy L, Ertz-Archambault N, Patel N, Rodriguez EA, Lizaola-Mayo B, Lehrer M, Thorpe CS, Yu NY, Esplin ED, Nussbaum RL, Sharp RR, Azevedo C, Klint M, Hager M, Macklin-Mantia S, Bryce AH, Bekaii-Saab TS, Sekulic A, Stewart AK (2021) Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome. JAMA Oncol 7:230–237. https://doi.org/10.1001/jamaoncol.2020.6252

Article  PubMed  Google Scholar 

Al-Sukhun S, Masannat Y, Wegman-Ostrosky T, Shrikhande SV, Manirakiza A, Fadelu T, Rebbeck TR (2023) Germline testing around the globe: challenges in different practice settings. Am Soc Clin Oncol Educ Book. https://doi.org/10.1200/EDBK_390522

Article  PubMed  Google Scholar 

Achatz MI, Caleffi M, Guindalini R, Marques RM, Nogueira-Rodrigues A, Ashton-Prolla P (2020) Recommendations for advancing the diagnosis and management of hereditary breast and ovarian cancer in Brazil. JCO Glob Oncol. https://doi.org/10.1200/JGO.19.00170

Article  PubMed  PubMed Central  Google Scholar 

Malhotra H, Kowtal P, Mehra N, Pramank R, Sarin R, Rajkumar T, Gupta S, Bapna A, Bhattacharyya GS, Gupta S, Maheshwari A, Mannan AU, Reddy Kundur R, Sekhon R, Singhal M, Smruti BK, SP S, Suryavanshi M, Verma A, (2020) Genetic counseling, testing, and management of HBOC in India: an expert consensus document from indian society of medical and pediatric oncology. JCO Glob Oncol. https://doi.org/10.1200/JGO.19.00381

Article  PubMed  PubMed Central  Google Scholar 

Xie F, Wang S (2021) Clinical practice guideline of BRCA1/2 testing for patients with breast cancer: Chinese society of breast surgery (CSBrS) practice guideline 2021. Chin Med J (Engl) 134:1516. https://doi.org/10.1097/CM9.0000000000001587

Article  PubMed  Google Scholar 

Department of Health, South Africa (2018) Clinical guidelines for breast cancer control and management. https://knowledgehub.health.gov.za/system/files/elibdownloads/2023-04/Clinical%2520guidelines%2520Breast%2520Cancer_0.pdf. Accessed 13 Jul 2023

NCCN Guidelines (2016) Genetic/familial high-risk assessment: breast and ovarian v2.2016. In: Natl. Compr. Cancer Netw. NCCN.org. Accessed 17 Aug 2016

Yadav S, Couch FJ (2019) Germline genetic testing for breast cancer risk: the past, present, and future. Am Soc Clin Oncol Educ Book. https://doi.org/10.1200/EDBK_238987

Article  PubMed  Google Scholar 

StatsSA (2024) Statistics South Africa | Census dissemination. https://census.statssa.gov.za/#/statsbytheme. Accessed 27 Jun 2024

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229–263. https://doi.org/10.3322/caac.21834

Article  PubMed  Google Scholar 

Jiagge E, Jibril AS, Chitale D, Bensenhaver JM, Awuah B, Hoenerhoff M, Adjei E, Bekele M, Abebe E, Nathanson SD, Gyan K, Salem B, Oppong J, Aitpillah F, Kyei I, Bonsu EO, Proctor E, Merajver SD, Wicha M, Stark A, Newman LA (2016) Comparative analysis of breast cancer phenotypes in African American, white American, and west versus east african patients: correlation between African ancestry and triple-negative breast cancer. Ann Surg Oncol 23:3843–3849. https://doi.org/10.1245/s10434-016-5420-z

Article  PubMed  Google Scholar 

McCormack VA, Joffe M, van den Berg E, Broeze N, dos Santos SI, Romieu I, Jacobson JS, Neugut AI, Schüz J, Cubasch H (2013) Breast cancer receptor status and stage at diagnosis in over 1200 consecutive public hospital patients in Soweto, South Africa: a case series. Breast Cancer Res BCR 15:R84. https://doi.org/10.1186/BCR3478

Article  PubMed  Google Scholar 

Greenup R, Buchanan A, Lorizio W, Rhoads K, Chan S, Leedom T, King R, McLennan J, Crawford B, Kelly Marcom P, Shelley Hwang E (2013) Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort. Ann Surg Oncol 20:3254–3258. https://doi.org/10.1245/s10434-013-3205-1

Article  PubMed  Google Scholar 

Dickens C, Pfeiffer RM, Anderson WF, Duarte R, Kellett P, Schüz J, Kielkowski D, McCormack VA (2016) Investigation of breast cancer sub-populations in black and white women in South Africa. Breast Cancer Res Treat 160:531–537. https://doi.org/10.1007/S10549-016-4019-1

Article  PubMed  Google Scholar 

de Wit E, Delport W, Rugamika CE, Meintjes A, Möller M, van Helden PD, Seoighe C, Hoal EG (2010) Genome-wide analysis of the structure of the South African Coloured Population in the Western Cape. Hum Genet 128:145–153. https://doi.org/10.1007/s00439-010-0836-1

Article  PubMed  Google Scholar 

Invitae Corporation (2023) Genetic testing: invitae DNA testing for better health. In: Genet Test Invit DNA test. Better health. https://www.invitae.com/en. Accessed 7 Jul 2023

Van Der Merwe NC, Oosthuizen J, Theron M, Chong G, Foulkes WD (2020) The contribution of large genomic rearrangements in BRCA1 and BRCA2 to South African familial breast cancer. BMC Cancer. https://doi.org/10.1186/S12885-020-06917-Y

Article  PubMed  PubMed Central  Google Scholar 

Technology & quality faqs | For providers | Invitae. https://www.invitae.com/us/provider-faqs/tech-and-quality. Accessed 16 Jan 2024

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho Y-Y, Kobayashi Y, Patil N, Thusberg J, Westbrook M, Topper S, The Invitae Clinical Genomics Group (2017) Sherloc: a comprehensive refinement of the ACMG–AMP variant classification criteria. Genet Med 19:1105–1117. https://doi.org/10.1038/gim.2017.37

Article  PubMed  PubMed Central  Google Scholar 

van der Merwe NC, Ntaita KS, Stofberg H, Combrink HM, Oosthuizen J, Kotze MJ (2022) Implementation of multigene panel testing for breast and ovarian cancer in South Africa: a step towards excellence in oncology for the public sector. Front Oncol 12:938561. https://doi.org/10.3389/fonc.2022.938561

Article